Product
Aramchol
2 clinical trials
2 indications
Indication
Primary Sclerosing CholangitisIndication
NASHClinical trial
A Proof of Concept, Prospective, Randomized, Placebo-controlled, Double-blind, Study to Evaluate the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Patients With Primary Sclerosing CholangitisStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability of Aramchol and to Determine the Mass Balance Recovery, Metabolite Profile and Metabolite Identification to Healthy Male SubjectsStatus: Completed, Estimated PCD: 2020-08-11